Nagashima Goro, Okamoto Noriyoshi, Okuda Muneo, Nakashima Koji, Noda Masayuki, Itokawa Hiroshi, Suzuki Ryuta, Fujimoto Tsukasa, Marumo Kenji
Department of Neurosurgery, Fujigaoka Hospital, Showa University, 1-30 Fujigaoka, Yokohama, Kanagawa, 227-8501, Japan.
J Infect Chemother. 2008 Apr;14(2):147-50. doi: 10.1007/s10156-007-0582-z. Epub 2008 Apr 30.
A 67-year-old man who had twice previously undergone operations for a tuberculum sellae meningioma was admitted to hospital for further treatment. After the third surgical intervention, the patient developed persistent low-grade fever and impaired consciousness. Computed tomography, 1 week after surgery, showed postsurgical hydrocephalus. Cerebrospinal fluid (CSF) studies revealed high intracranial pressure (above 30 cm H2O), and increased cell count (1232/3). One week after the ventricular drainage, coagulase-negative Staphylococcus epidermidis was recovered from his CSF, and antimicrobial susceptibility results indicated that the organism was methicillin-resistant. After 14 days of intravenous vancomycin (VCM) administration failed, linezolid (LZD) was initialized intravenously, resulting in a resolution of the meningitis. After a ventriculoperitoneal shunt procedure was performed, LZD was continued orally, which resulted in a cure. CSF penetration by VCM is reported to be poor, i.e., approximately 10% of serum concentration, which may explain its lack of efficacy. In this case, the penetration of LZD into the CSF was 58.9% of the peak value and 133% of the trough value of serum concentrations. LZD must be considered one of the first-line treatments against surgical-site infection in neurosurgery caused by methicillin-resistant Staphylococci.
一名67岁男性,曾因鞍结节脑膜瘤接受过两次手术,此次因进一步治疗入院。第三次手术干预后,患者出现持续低热和意识障碍。术后1周的计算机断层扫描显示术后脑积水。脑脊液(CSF)检查显示颅内压升高(超过30 cm H2O),细胞计数增加(1232/3)。脑室引流1周后,从其脑脊液中分离出表皮葡萄球菌,抗菌药敏结果表明该菌对甲氧西林耐药。静脉注射万古霉素(VCM)14天治疗失败后,开始静脉注射利奈唑胺(LZD),脑膜炎症状得到缓解。在进行脑室腹腔分流术后,继续口服LZD,最终治愈。据报道,VCM在脑脊液中的穿透性较差,即约为血清浓度的10%,这可能解释了其治疗无效的原因。在本病例中,LZD在脑脊液中的穿透率为血清浓度峰值的58.9%,谷值的133%。LZD必须被视为治疗耐甲氧西林葡萄球菌引起的神经外科手术部位感染的一线治疗药物之一。